Downregulation of miR-130b-3p is associated with the progression of type 2 diabetic nephropathy
American Journal of Translational Research · 2026 · 18 (5) · 4410-4419
DOI: 10.62347/jldi4762 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Translational Research, 2026. Verfasst von Xukai Hua und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine, Southern Medical University Guangzhou, Guangdong, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First School of Clinical Medicine, Southern Medical University Guangzhou, Guangdong, China.
- Department of Laboratory, Foresea Life Insurance Guangzhou General Hospital Guangzhou, Guangdong, China.
- Xiaolan People's Hospital of Zhongshan Zhongshan, Guangdong, China.
- Basic Laboratory of General Hospital of Southern Theater Command Guangzhou, Guangdong, China.
Zitieren
APA
Hua, X., Zhu, X., Wu, J., & Zhang, H. (2026). Downregulation of miR-130b-3p is associated with the progression of type 2 diabetic nephropathy. American Journal of Translational Research, 18(5), 4410-4419. https://doi.org/10.62347/jldi4762
Vancouver
Hua X, Zhu X, Wu J, Zhang H. Downregulation of miR-130b-3p is associated with the progression of type 2 diabetic nephropathy. American Journal of Translational Research. 2026;18(5):4410-4419. doi:10.62347/jldi4762
BibTeX
@article{Hua2026,
author = {Hua, Xukai and Zhu, Xiaoyan and Wu, Jianzhuo and Zhang, Hongbin},
title = {Downregulation of miR-130b-3p is associated with the progression of type 2 diabetic nephropathy},
journal = {American Journal of Translational Research},
year = {2026},
volume = {18},
number = {5},
pages = {4410--4419},
doi = {10.62347/jldi4762}
}
EUVIMED